Q3 2021 13F Holders as of 30 Sep 2021
-
Type / Class
-
Equity / Common Stock, par value $0.001 per share
-
Shares outstanding
-
27.2M
-
Number of holders
-
150
-
Total 13F shares, excl. options
-
19.1M
-
Shares change
-
-1.44M
-
Total reported value, excl. options
-
$909M
-
Value change
-
-$50.3M
-
Put/Call ratio
-
0.54
-
Number of buys
-
77
-
Number of sells
-
-55
-
Price
-
$47.78
Significant Holders of Arcturus Therapeutics Holdings Inc. - Common Stock, par value $0.001 per share (ARCT) as of Q3 2021
174 filings reported holding ARCT - Arcturus Therapeutics Holdings Inc. - Common Stock, par value $0.001 per share as of Q3 2021.
Arcturus Therapeutics Holdings Inc. - Common Stock, par value $0.001 per share (ARCT) has 150 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 19.1M shares
of 27.2M outstanding shares and own 70.19% of the company stock.
Largest 10 shareholders include FEDERATED HERMES, INC. (3.05M shares), ARK Investment Management LLC (2.53M shares), BlackRock Inc. (1.72M shares), STATE STREET CORP (1.47M shares), Nikko Asset Management Americas, Inc. (1.36M shares), Sumitomo Mitsui Trust Holdings, Inc. (1.36M shares), VANGUARD GROUP INC (1.11M shares), FMR LLC (1.07M shares), Bank Julius Baer & Co. Ltd, Zurich (680K shares), and ACT Capital, L.L.C. (455K shares).
This table shows the top 150 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.